Kanjinti
Active Ingredient(s): Trastuzumab-annsFDA Approved: * June 13, 2019
Pharm Company: * AMGEN INC
Category: Cancer
Trastuzumab, sold under the brand name Herceptin among others, is a monoclonal antibody used to treat breast cancer and stomach cancer.[3][4][5][6] It is specifically used for cancer that is HER2 receptor positive.[3] It may be used by itself or together with other chemotherapy medication.[3] Trastuzumab is given by slow injection into a vein and injection just under the skin.[3]&am... [wikipedia]
* May have multiple approval dates, manufacturers, or labelers.